INHIBITION OF SUPRAOPTIC VASOPRESSIN NEURONS FOLLOWING SYSTEMIC CLONIDINE

被引:5
作者
BAILEY, ART
CLARKE, G
WAKERLEY, JB
机构
[1] Department of Anatomy, School of Medical Sciences, University of Bristol, Bristol, BS8 1TD, University Walk
关键词
CLONIDINE; ALPHA-2; ADRENOCEPTORS; SUPRAOPTIC VASOPRESSIN NEURONS; PHASIC ACTIVITY;
D O I
10.1016/0028-3908(94)90010-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Experiments were undertaken in urethane-anaesthetized rats to investigate the effects of systemic clonidine on the firing of supraoptic vasopressin (VP) neurones, which were identified by their characteristic phasic activity pattern. Injection of clonidine (50 mu g/kg i.v.) reduced the firing of all 16 VP neurones tested, and their overall mean activity decreased from 5.09 +/- 1.01 to 1.63 +/- 0.64 spikes/second (P < 0.02). In VP cells which were already firing phasically before clonidine, the inhibition resulted in complete quiescence. In VP cells which were originally continuously active, the inhibition resulted in a switch to phasic activity. This inhibitory effect, which was prevented by prior injection of the alpha-2 antagonist idazoxan (0.5 mg/kg), had a mean duration of 11.8 +/- 1.8 min. Subsequent experiments revealed that i.v. clonidine (50 mu g/kg) caused a transient rise in blood pressure, but this had a shorter time-course and was unlikely to account for the prolonged neuronal inhibition. It was concluded that systemic clonidine acts centrally to suppress the activity of hypothalamic VP neurones, thereby explaining the fall in plasma VP levels found in previous studies.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 21 条
[1]  
BAILEY ART, 1993, BR J PHARM, V108
[2]   OPPOSING ALPHA-ADRENERGIC AND BETA-ADRENERGIC MECHANISMS MEDIATE DOSE-DEPENDENT ACTIONS OF NORADRENALINE ON SUPRAOPTIC VASOPRESSIN NEURONS INVIVO [J].
DAY, TA ;
RANDLE, JCR ;
RENAUD, LP .
BRAIN RESEARCH, 1985, 358 (1-2) :171-179
[3]   STUDIES ON RX781094 - A SELECTIVE, POTENT AND SPECIFIC ANTAGONIST OF ALPHA-2-ADRENOCEPTORS [J].
DOXEY, JC ;
ROACH, AG ;
SMITH, CFC .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 78 (03) :489-505
[4]   MECHANISM OF ALPHA-2-ADRENOCEPTOR AGONIST-INDUCED DIURESIS [J].
GELLAI, M ;
EDWARDS, RM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (02) :F317-F323
[5]   CHARACTERIZATION OF HYPOTHALAMIC NORADRENALINE RECEPTORS IN THE SUPRAOPTIC NUCLEUS AND PERIVENTRICULAR REGION OF THE PARAVENTRICULAR NUCLEUS OF MICE INVITRO [J].
INENAGA, K ;
DYBALL, REJ ;
OKUYA, S ;
YAMASHITA, H .
BRAIN RESEARCH, 1986, 369 (1-2) :37-47
[6]   ALPHA2-ADRENERGIC STIMULATION WITHIN THE NUCLEUS-TRACTUS-SOLITARIUS ATTENUATES VASOPRESSIN RELEASE INDUCED BY DEPLETION OF CARDIOVASCULAR VOLUME [J].
IOVINO, M ;
VANACORE, A ;
STEARDO, L .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 37 (04) :821-824
[7]   ALPHA-2-ADRENOCEPTOR MODULATION OF A1 NORADRENERGIC NEURON INPUT TO SUPRAOPTIC VASOPRESSIN CELLS [J].
KHANNA, S ;
SIBBALD, JR ;
DAY, TA .
BRAIN RESEARCH, 1993, 613 (01) :164-167
[8]   THE ROLE OF CENTRAL ALPHA-1-ADRENOCEPTOR AND ALPHA-2-ADRENOCEPTOR IN THE REGULATION OF VASOPRESSIN RELEASE AND THE CARDIOVASCULAR-SYSTEM [J].
KIMURA, T ;
SHOJI, M ;
IITAKE, K ;
OTA, K ;
MATSUI, K ;
YOSHINAGA, K .
ENDOCRINOLOGY, 1984, 114 (04) :1426-1432
[9]  
LIGHTMAN SL, 1984, EXP BRAIN RES, V55, P145
[10]   ELECTROPHYSIOLOGICAL EVIDENCE FOR ACTIVATION OF SUPRAOPTIC NEURONS DURING RELEASE OF OXYTOCIN [J].
LINCOLN, DW ;
WAKERLEY, JB .
JOURNAL OF PHYSIOLOGY-LONDON, 1974, 242 (02) :533-554